Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ORGS | US
0.49
16.90%
Healthcare
Biotechnology
30/06/2024
16/10/2024
3.39
2.85
3.49
2.76
Orgenesis Inc. a biotech company focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company was formerly known as Business Outsourcing Service Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown Maryland.
View LessLow Debt to Equity (< 0.25)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
135.3%1 month
3492.2%3 months
2047.2%6 months
1459.9%-
-
1.26
-0.84
0.43
-4.98
47.08
-
-19.06M
16.17M
16.17M
-
-1.65K
-
117.70
-727.25
2.39
1.33
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
1.74
Range1M
5.07
Range3M
5.07
Rel. volume
0.27
Price X volume
94.59K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
ICU | ICU | Biotechnology | 4.2 | 17.61M | 2.44% | n/a | -45.50% |
Athira Pharma Inc | ATHA | Biotechnology | 0.4546 | 17.47M | 2.30% | n/a | 1.69% |
Synlogic Inc | SYBX | Biotechnology | 1.44 | 16.84M | 2.13% | n/a | 0.00% |
IN8bio Inc. Common Stock | INAB | Biotechnology | 0.2289 | 16.61M | -2.18% | n/a | 43.30% |
Can-Fite BioPharma Ltd | CANF | Biotechnology | 2.7 | 16.46M | -1.82% | n/a | 0.64% |
Evaxion Biotech A/S | EVAX | Biotechnology | 2.71 | 15.99M | 4.23% | n/a | 837.11% |
LYRA THERAPEUTICS INC | LYRA | Biotechnology | 0.2402 | 15.72M | 5.17% | n/a | 118.63% |
ImmunoPrecise Antibodies Ltd | IPA | Biotechnology | 0.5611 | 15.72M | -1.56% | n/a | 49.00% |
Cara Therapeutics Inc | CARA | Biotechnology | 0.265 | 14.97M | 3.92% | n/a | 406.66% |
Indaptus Therapeutics Inc. Common Stock | INDP | Biotechnology | 1.43 | 14.58M | 12.60% | n/a | 2.12% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.6542 | 9.49M | -5.19% | 0.04 | 16.03% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2051 | 3.68M | -6.82% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.09 | 2.84M | -0.91% | n/a | 9.62% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.01 | 897.66K | -0.99% | n/a | -37.05% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 60.42 | 0 | 2.63% | n/a | |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 4.21 | 0 | 3.19% | n/a | |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.5 | 0 | 1.42% | n/a | |
Urban One Inc | UONEK | Broadcasting - Radio | 1.05 | 0 | 6.06% | n/a | |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 14.77 | 0 | 1.65% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -4.98 | 0.53 | Cheaper |
Ent. to Revenue | 47.08 | 4,005.99 | Cheaper |
PE Ratio | - | 40.42 | - |
Price to Book | 1.26 | 15.30 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 2,047.16 | 72.92 | Riskier |
Debt to Equity | -0.84 | -1.24 | Expensive |
Debt to Assets | 0.43 | 0.25 | Expensive |
Market Cap | 16.17M | 3.78B | Emerging |